Literature DB >> 1152922

Lymphocyte stimulation in hepatitis B infections.

M J Tong, A M Wallace, R L Peters, T B Reynolds.   

Abstract

Cell-mediated responses in patients with acute and chronic forms of Type B hepatitis were tested by lymphocyte transformation to purified hepatitis surface antigen (HBS Ag) and to phytohemagglutinin, by dinitrochlorobenzene sensitization and by response to skin-test antigens. Although absent during acute Type B hepatitis, lymphocyte transformation by HBS Ag appeared during early convalescence and remained detectable for six years after recovery. Patients with Type B chronic active hepatitis with increased serum transaminase levels showed a partial lymphocyte transformation with HBS Ag, whereas those with normal transaminase values demonstrated no transformation. Patients with Type B chronic persistent hepatitis and carriers of HBS Ag did not have lymphocyte transformation. Normal responses to dinitrochlorobenzene, intradermal skin tests and phytohemmaglutinin were found in all patients with acute, chronic active or chronic persistent hepatitis and carriers. These results indicate that recovery from Type B hepatitis is associated with the ability to elicit a specific lymphocyte response to HBS Ag.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1152922     DOI: 10.1056/NEJM197508142930702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  27 in total

1.  Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays.

Authors:  P A De Moerloose; I H Frazer; W A Sewell; E J Collins; I R Mackay
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

2.  Variable effect of encephalomyocarditis virus on host defense mechanisms.

Authors:  H Faden; L A Glasgow; J C Overall
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens.

Authors:  A K Lee; M Eisinger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

4.  Release of e antigen from a Dane particle-rich preparation of hepatitis B virus.

Authors:  K C Lam; M J Tong; J Rakela
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.

Authors:  P J Wismans; J van Hattum; G C De Gast; H J Endeman; J Poel; B Stolk; T Maikoe; G C Mudde
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

6.  Cellular immunity to nucleocapsid and pre-S determinants in asymptomatic carriers of hepatitis B virus.

Authors:  S Vento; S H Chen; G Giuliani-Piccari; C J O'Brien; P R Dal Monte; A L Eddleston; C R Howard; R Williams
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

7.  T-lymphocytes and hepatitis B serology.

Authors:  E Kaklamani; D Trichopoulos; G Papaevangelou; M Drouga; D Karalis; G Papoutsakis
Journal:  Infection       Date:  1978       Impact factor: 3.553

8.  Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.

Authors:  B Hafkin; R B Pollard; M L Tiku; W S Robinson; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  Cell-mediated immunity to hepatitis B surface antigen in man.

Authors:  R G Hanson; J H Hoofnagle; G Y Minuk; R H Purcell; J L Gerin
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

10.  Anti-LSP antibodies in acute liver disease.

Authors:  R Meliconi; A Perperas; D Jensen; A Alberti; I G McFarlane; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.